 Mildly affected patients experience a compensated haemolytic anaemia because mutations affect stability of the enzyme.Moderately and severely affected individuals have enzymes with dysfunctional catalytic sites, rendering it unable to participate in detoxification reactions.Physiological symptoms include metabolic acidosis, neurological defects, and increased susceptibility to pathogenic infections.